Carl Byrnes
Stock Analyst at Northland Capital Markets
(3.28)
# 835
Out of 5,182 analysts
27
Total ratings
50%
Success rate
19.2%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Initiates: Outperform | $10 | $4.56 | +119.30% | 1 | Mar 5, 2026 | |
| BWAY BrainsWay | Maintains: Outperform | $9.5 → $12 | $16.50 | -30.30% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $18.46 | +197.94% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $21.41 | +44.79% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.50 | +177.78% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.96 | +206.12% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.65 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $13.93 | +79.47% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $1.82 | +13,086.81% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $29.40 | +172.11% | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $3.34 | +588.62% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $1.91 | +1,156.54% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.55 | +78,331.37% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.19 | - | 1 | Sep 27, 2017 |
AVITA Medical
Mar 5, 2026
Initiates: Outperform
Price Target: $10
Current: $4.56
Upside: +119.30%
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $9.5 → $12
Current: $16.50
Upside: -30.30%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $18.46
Upside: +197.94%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $21.41
Upside: +44.79%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.50
Upside: +177.78%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.96
Upside: +206.12%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.65
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $13.93
Upside: +79.47%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $1.82
Upside: +13,086.81%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $29.40
Upside: +172.11%
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $3.34
Upside: +588.62%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $1.91
Upside: +1,156.54%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.55
Upside: +78,331.37%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.19
Upside: -